1Yoshikaua T, Port JD, Asanok K, et al. Cardial receptor adrenergic effects of carvedilol[J]. Eur Heart J, 1996,17[ Suppl] :b8-b16.
2Yue TL, Cheng HY, Lysko PG, et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger[J] .J Pharmacol Exp Ther, 1992,263(2):92-98.
3Bill A, Slivjak M, DiMartino MJ, et al. Cardioproteeive effects of carvedilol, a novel beta adrenocetor antagonist with vasodilating properties, in anaesthetized minipigs : comparison with propranolel [ J ]. Cardiovasc Res, 1992,26(12) :518-525.
4Feuerstein GZ, Bfila A, Ruffolo RR. Protedive effect of eavedilor in the myocardian[ J] .Am J Cardiol,1997,80(11A) :41L-45L.
5Olsen SL, Gilberl EM, Renlund DG, et al. Carvedilor improves left ventficular and symptoms in chronic heart failure: a double-blind randomized study[J] .J Am Coil Cardiol, 1995,25(6):1225-1231.
6Metar M, Nardi M, Giubbini R, et al. Effect of short-and long-term cavedilol adminstration on rest and exercise hemodynamie variables.Exercise capacity and clinical condition in patients with idiopthic dilated cardiomyopathy[J] .J Am Cou Cardiol, 1994,24(7):1678-1687.
7Krum H, Sackner-Bemstein JD, Gold smith RL, et al. Double blind placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure[ J]. Circulation, 1995, 12(6) :1499-1506.
8Australial/New leman Heart Failure Kcsearch Collaborative Group. Effects of cavedilol in pathients with congestive heart failure due to isch-aemic heart disease : final results from the ANZ heart failure research collaborative trial [ J ]. Lancet, 1997,349 ( 9211 ) : 2312-231 g.
9Packer M, Antonopoulos GV, Berlin JA, et al. Comparative effect of carvedilol and metoprolol on left ventricular ejection fraction inheart failure :results of a meta-analysis[J] .Am Heart J,2001,141(6) :899-907.
10Adams KF Jr. Which B-blocker for heart failure[J]? Am Heart J,2001,141(6) :884-888.
